Paper7530461
The selectins and their ligands.
Rosen SD and 1 other. Curr Opin Cell Biol, 1994. Cited by 395 papers, by iCite.
Cite this record
ConductScience Library. The selectins and their ligands. Papers, record 7530461. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/7530461
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Publication types
- Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S., Review
- PubMed
Topics19
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Cell Adhesion Molecules | Major topic |
| Platelet Membrane Glycoproteins | Major topic |
| Animals | |
| Carbohydrate Metabolism | |
| Carbohydrate Sequence | |
| Carbohydrates | |
| Cell Movement | |
| E-Selectin | |
| Endothelium, Vascular | |
| Humans | |
| Inflammation | |
| L-Selectin | |
| Leukocytes | |
| Ligands | |
| Models, Molecular | |
| Molecular Sequence Data | |
| Oligosaccharides | |
| P-Selectin | |
| Sialyl Lewis X Antigen |
Source PubMed
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| GM23547 | NIGMS NIH HHS | United States | R01GM023547 | PubMed and NIH | NIH RePORTER |
| R37GM023547 | NIH | NIH RePORTER |
Cited by98
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 395 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 40879088 | Efficient and Traceless Aptamer-Based Serial Selection of Naïve and Early Memory CD8 T Cells for CAR T Cell Therapy. | Adv Healthc Mater | 2026 | https://conductscience.org/library/papers/40879088 | PubMed |
| 40683091 | Discovery and characterization of vertebrate sialoglycan-binding proteins. | Semin Immunol | 2025 | https://conductscience.org/library/papers/40683091 | PubMed |
| 39868376 | CA19-9-related macrophage polarization drives poor prognosis in HCC after immune checkpoint inhibitor treatment. | Front Oncol | 2024 | https://conductscience.org/library/papers/39868376 | PubMed |
| 39596031 | Mechanistic and Therapeutic Implications of Protein and Lipid Sialylation in Human Diseases. | Int J Mol Sci | 2024 | https://conductscience.org/library/papers/39596031 | PubMed |
| 38586333 | Potential new cancer biomarkers revealed by quantum chemistry associated with bioinformatics in the study of selectin polymorphisms. | Heliyon | 2024 | https://conductscience.org/library/papers/38586333 | PubMed |
| 38066482 | Sec1 regulates intestinal mucosal immunity in a mouse model of inflammatory bowel disease. | BMC Immunol | 2023 | https://conductscience.org/library/papers/38066482 | PubMed |
| 36584297 | QnAs with Carolyn R. Bertozzi. | Proc Natl Acad Sci U S A | 2023 | https://conductscience.org/library/papers/36584297 | PubMed |
| 36077781 | Aberrant Sialylation in Cancer: Therapeutic Opportunities. | Cancers (Basel) | 2022 | https://conductscience.org/library/papers/36077781 | PubMed |
| 35400524 | Pathological implication of protein post-translational modifications in cancer. | Mol Aspects Med | 2022 | https://conductscience.org/library/papers/35400524 | PubMed |
| 35308080 | Synthetic linear glycopolymers and their biological applications. | J Carbohydr Chem | 2021 | https://conductscience.org/library/papers/35308080 | PubMed |
| 35249189 | Therapeutic Outcome of Anti-inflammatory and Antioxidative Medicines on the Dermonecrotic Activity of Cerastes cerastes Venom. | Inflammation | 2022 | https://conductscience.org/library/papers/35249189 | PubMed |
| 34851463 | Native glycan fragments detected by MALDI mass spectrometry imaging are independent prognostic factors in pancreatic ductal adenocarcinoma. | EJNMMI Res | 2021 | https://conductscience.org/library/papers/34851463 | PubMed |
| 34782709 | Finding the sweet spot: glycosylation mediated regulation of intestinal inflammation. | Mucosal Immunol | 2022 | https://conductscience.org/library/papers/34782709 | PubMed |
| 34161162 | Tumor-Associated Glycans as Targets for Immunotherapy: The Wistar Institute Experience/Legacy. | Monoclon Antib Immunodiagn Immunother | 2021 | https://conductscience.org/library/papers/34161162 | PubMed |
| 33182593 | Dimeric and Multimeric DNA Aptamers for Highly Effective Protein Recognition. | Molecules | 2020 | https://conductscience.org/library/papers/33182593 | PubMed |
| 33144696 | Insights into the role of sialylation in cancer progression and metastasis. | Br J Cancer | 2021 | https://conductscience.org/library/papers/33144696 | PubMed |
| 32825463 | Differential Labeling of Glycoproteins with Alkynyl Fucose Analogs. | Int J Mol Sci | 2020 | https://conductscience.org/library/papers/32825463 | PubMed |
| 31907993 | Regulation of neutrophil function by selective targeting of glycan epitopes expressed on the integrin CD11b/CD18. | FASEB J | 2020 | https://conductscience.org/library/papers/31907993 | PubMed |
| 31314995 | Glycosylation and its implications in breast cancer. | Expert Rev Proteomics | 2019 | https://conductscience.org/library/papers/31314995 | PubMed |
| 31267247 | "Stuck on sugars - how carbohydrates regulate cell adhesion, recognition, and signaling". | Glycoconj J | 2019 | https://conductscience.org/library/papers/31267247 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/7530461
GET https://conductscience.org/api/papers/v1/7530461/cited_by?page=2